Journal of Clinical Investigation · 2006 · 286 citations · 36 references
Life SciencesEndocrinologyImmunologyAutoimmunityCellular ImmunologyImmunotherapyAutoantigensAutoimmune Disease ImmunotherapyAutoimmune DiseasesAutoimmune RegulationDiabetes MellitusTolerance MechanismsAnimal Disease ModelsAutoimmune Disease ToleranceBystander SuppressionDisease Remission InductionMurine ModelsPeptide-based ImmunotherapySystemic Immune ResponseType 1 Diabetes Models
Safe induction of autoantigen-specific long-term tolerance is the "holy grail" for the treatment of autoimmune diseases. In animal models of type 1 diabetes, oral or i.n. immunization with islet antigens induces Tregs that are capable of bystander suppression. However, such interventions are only effective early in the prediabetic phase. Here, we demonstrate that a novel combination treatment with anti-CD3epsilon-specific antibody and i.n. proinsulin peptide can reverse recent-onset diabetes in 2 murine diabetes models with much higher efficacy than with monotherapy with anti-CD3 or antigen alone. In vivo, expansion of CD25(+)Foxp3(+) and insulin-specific Tregs producing IL-10, TGF-beta, and IL-4 was strongly enhanced. These cells could transfer dominant tolerance to immunocompetent recent-onset diabetic recipients and suppressed heterologous autoaggressive CD8 responses. Thus, combining a systemic immune modulator with antigen-specific Treg induction is more efficacious in reverting diabetes. Since Tregs act site-specifically, this strategy should also be expected to reduce the potential for systemic side effects.
36
CD4+CD25+ Immunoregulatory T Cells
Rebecca S. McHugh, Matthew J. Whitters, Ciriaco A. Piccirillo et al. · Immunity · 2002 · 1.4K citations · Full text
Anti-CD3 Monoclonal Antibody in New-Onset Type 1 Diabetes Mellitus
Kevan C. Herold, William Hagopian, Julie Auger et al. · New England Journal of Medicine · 2002 · 1.2K citations · Full text
Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes
Bart Keymeulen, Evy Vandemeulebroucke, Anette G. Ziegler et al. · New England Journal of Medicine · 2005 · 1.1K citations · Full text
Medicine, Endocrinology, Immunology +17
Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice
Maki Nakayama, Norio Abiru, Hiroaki Moriyama et al. · Nature · 2005 · 745 citations · Full text